Brief: China Biotech Services Holdings Says Expected To Record A Net Loss Of Not Less Than HK$60 Mln For Q3
30/10/2019 12:44
Oct 30 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* EXPECTED TO RECORD A NET LOSS OF NOT LESS THAN HK$60
MILLION FOR
2019 Q3 PERIOD
* EXPECTED INCREASE IN NET LOSS DUE TO INCREASE RAW
MATERIAL,
STAFF COSTS AND OTHER DIRECT COSTS, AMONG OTHER THINGS
Source text for Eikon: ID:nHKS7VkWQL
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)